Adverse effects of TNF inhibitors in SpA: are they different from RA?

P.D. Sampaio-Barros, I.E. van der Horst-Bruinsma

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)747-763
JournalBaillière's Best Practice and Research. Clinical Rheumatology
Volume28
Issue number5
DOIs
Publication statusPublished - 2014

Cite this